Depressive syndromes in neurological disorders

被引:3
作者
Julian Hellmann-Regen
Dominique Piber
Kim Hinkelmann
Stefan M. Gold
Christoph Heesen
Carsten Spitzer
Matthias Endres
Christian Otte
机构
[1] Charité Universitätsmedizin Berlin,Klinik für Psychiatrie und Psychotherapie
[2] Universitätsklinikum Hamburg-Eppendorf,Zentrum für Molekulare Neurobiologie
[3] Universitätsklinikum Hamburg-Eppendorf,Klinik für Neurologie
[4] Asklepios Fachklinikum Tiefenbrunn,Klinik für Neurologie
[5] Charité Universitätsmedizin Berlin,Centrum für Schlaganfallforschung Berlin
[6] Charité Universitätsmedizin Berlin,ExzellenzCluster NeuroCure
[7] Charité Universitätsmedizin Berlin,undefined
来源
European Archives of Psychiatry and Clinical Neuroscience | 2013年 / 263卷
关键词
Depression; Neuropsychiatry; Psychosomatic medicine; Neurological disorders;
D O I
暂无
中图分类号
学科分类号
摘要
Depressive syndromes represent a common and often characteristic feature in a number of neurological disorders. One prominent example is the development of post-stroke depression, which can be observed in more than one-third of stroke survivors in the aftermath of an ischemic stroke. Thus, post-stroke depression represents one of the most prevalent, disabling, and potentially devastating psychiatric post-stroke complications. On the other hand, depressive syndromes may also be considered as a risk factor for certain neurological disorders, as recently revealed by a meta-analysis of prospective cohort studies, which demonstrated an increased risk for ischemic events in depressed patients. Moreover, depressive syndromes represent common comorbidities in a number of other neurological disorders such as Parkinson’s disease, multiple sclerosis, or epilepsy, in which depression has a strong impact on both quality of life and outcome of the primary neurological disorder.
引用
收藏
页码:123 / 136
页数:13
相关论文
共 955 条
[1]  
Aarsland D(2009)Memantine in patients with Parkinson’s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial Lancet Neurol 8 613-618
[2]  
Ballard C(2009)Neuropsychiatric symptoms in Parkinson’s disease Mov Disord 24 2175-2186
[3]  
Walker Z(2012)Depression in Parkinson disease–epidemiology, mechanisms and management Nat Rev Neurol 8 35-47
[4]  
Bostrom F(2012)Drug interactions in the treatment of depression in patients with ischemic heart disease J Clin Psychiatry 73 e1475-e1477
[5]  
Alves G(2010)Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms J Clin Psychiatry 71 1565-1575
[6]  
Kossakowski K(2010)Favorable effects of physical activity for recovery in temporal lobe epilepsy Epilepsia 51 76-79
[7]  
Leroi I(2010)The potential role of physical exercise in the treatment of epilepsy Epilepsy Behav 17 432-435
[8]  
Pozo-Rodriguez F(2008)Depression in multiple sclerosis: review and theoretical proposal J Int Neuropsychol Soc 14 691-724
[9]  
Minthon L(2013)The natural history of depression up to 15 years after stroke: the South London Stroke Register Stroke 44 1105-1110
[10]  
Londos E(2013)Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis Br J Psychiatry 202 14-21